miRNA-mediated loss of m6A increases nascent translation in glioblastoma

John P. Zepecki, David Karambizi, J. Eduardo Fajardo, Kristin M. Snyder, Charlotte Guetta-Terrier, Oliver Y. Tang, Jia Shu Chen, Atom Sarkar, Andras Fiser, Steven A. Toms, Nikos Tapinos

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Within the glioblastoma cellular niche, glioma stem cells (GSCs) can give rise to differentiated glioma cells (DGCs) and, when necessary, DGCs can reciprocally give rise to GSCs to maintain the cellular equilibrium necessary for optimal tumor growth. Here, using ribosome profiling, transcriptome and m6A RNA sequencing, we show that GSCs from patients with different subtypes of glioblastoma share a set of transcripts, which exhibit a pattern of m6A loss and increased protein translation during differentiation. The target sequences of a group of miRNAs overlap the canonical RRACH m6A motifs of these transcripts, many of which confer a survival advantage in glioblastoma. Ectopic expression of the RRACH-binding miR-145 induces loss of m6A, formation of FTO/AGO1/ILF3/miR-145 complexes on a clinically relevant tumor suppressor gene (CLIP3) and significant increase in its nascent translation. Inhibition of miR-145 maintains RRACH m6A levels of CLIP3 and inhibits its nascent translation. This study highlights a critical role of miRNAs in assembling complexes for m6A demethylation and induction of protein translation during GSC state transition.

Original languageEnglish (US)
Article numbere1009086
JournalPLoS genetics
Issue number3
StatePublished - Mar 8 2021

ASJC Scopus subject areas

  • Ecology, Evolution, Behavior and Systematics
  • Molecular Biology
  • Genetics
  • Genetics(clinical)
  • Cancer Research


Dive into the research topics of 'miRNA-mediated loss of m6A increases nascent translation in glioblastoma'. Together they form a unique fingerprint.

Cite this